Medical Implant Business Investment Opportunities

Established medical equipment and surgical implants supply business based in Dubai, actively seeking investment to expand its operations. - Boasts over 500 supply contracts, ensuring a robust distribution network across 20 hospitals, 50 clinics, and 500 pharmacies. - Offers a diverse product portfolio including ortho-spine implants, artificial saliva, multivitamins, and various medical equipment and consumables. - All products are FDA-compliant, providing assurance of quality and safety to healthcare providers and patients. - The company's promoter brings 23 years of procurement and supply chain management experience within the medical industry, enhancing operational effectiveness. - Strong relationship management with healthcare entities, including physicians, surgeons, and home health service providers, facilitating smooth transactions and repeat business. - Target markets include chronic patients needing artificial saliva and patients requiring orthopaedic spinal implants, addressing critical healthcare needs. - Business is based in Dubai. Promoter is in India for a few days and will be back in Dubai in a few days. - We do not require high manpower as we only supply the products and don't manufacture them.

The company develops human bone tissue for implantation in patients with bone fractures, instability in the spine, or bone gaps following trauma or previous surgery. - We are currently in the development stage, hence there is no revenue generation and the figures are not given. - The product is tailored for a specific patient because it uses bone cells and blood components. - Therefore, this product is individualized for a patient and should not be rejected. - We have already successfully passed the FDA pre-IND process with a positive feedback. - Patents have already been issued in the EU, USA, Switzerland, and Israel. - The method, its efficiency, and safety were described in two scientific papers published in. Highly ranked peer-reviewed journals. - Have conducted preliminary testing to demonstrate the feasibility of the product. - Led by a highly qualified CEO who is an expert in bone cell culturing and has multiple qualifications like MD, MOrthop, MBA, and FRCS (England). - It is expected to require an additional 2 years after securing funding to obtain necessary approvals from the FDA and European authorities. - The bone grafting market is estimated to be above USD 10 billion. - Since currently there is no clinically used method for personalized bone grafting material supplementation, the appearance of such a product will even increase the market evaluation.

A Colombian company specializing in applied research, prototypes and the protection of intellectual property and rights. designs innovative solutions and transforms them into cost effective, commercially viable new products. - The company is capable of identifying market needs and developing cost-efficient products with innovative approaches and proprietary technology. - Currently focused on the development and manufacture of a new patented osteosynthesis implant for broken bones. - The company has established agreements with universities and research groups to enhance its innovative and developing capacity. - Has a strong nucleus of inventors and experts in various areas including economics, electronic engineering, mechanical systems, business and international relations, machine tooling, and intellectual property. - The revenue model is project-based, with an average of 2-3 projects per year and an average project duration of 1 to 2 years. Upon developing the new implants, the revenue model will be through supply of these products. - The company's current pipeline includes 3 projects in various stages of research and development. - Clients are mainly universities and research centres. Has established relations with more than fifteen service provider companies, collaborating with new companies for the development of a new product when needed.

A Colombian company specializing in applied research, prototypes and the protection of intellectual property and rights. designs innovative solutions and transforms them into cost effective, commercially viable new products. - The company is capable of identifying market needs and developing cost-efficient products with innovative approaches and proprietary technology. - Currently focused on the development and manufacture of a new patented osteosynthesis implant for broken bones. - The company has established agreements with universities and research groups to enhance its innovative and developing capacity. - Has a strong nucleus of inventors and experts in various areas including economics, electronic engineering, mechanical systems, business and international relations, machine tooling, and intellectual property. - The revenue model is project-based, with an average of 2-3 projects per year and an average project duration of 1 to 2 years. Upon developing the new implants, the revenue model will be through supply of these products. - The company's current pipeline includes 3 projects in various stages of research and development. - Clients are mainly universities and research centres. Has established relations with more than fifteen service provider companies, collaborating with new companies for the development of a new product when needed.